Developing autologous iPSC-based therapies for Parkinson’s disease treatment

Kim Raineri

28 February 2025

Interview

Implementing platform-based technologies to scale viral vector manufacturing consistently and efficiently

Xueyuan Liu

19 December 2024

Interview

Navigating the complexities of AAV and lentiviral vector characterization

Susumu Uchiyama

12 December 2024

Interview

History and progress in viral vector particle size distribution analysis

Steven Berkowitz

09 December 2024

Interview

Pioneering quality control in biomanufacturing of cell and gene therapies

Dhruv Sareen, Jonathan Rodriguez

05 December 2024

Interview

Troubleshooting process and analytical tool changes in an approved ATMP process

Maitane Ortiz, Marta Malo De Molina

03 December 2024

Interview

Process optimization for AAV-based gene therapy: insights on downstream purification

Srivatsan Ramesh

17 October 2024

Interview

Exploring innovations in CAR-T therapy for solid tumors: the role of automated systems, analytical testing, and AI

Arindam Mitra

02 October 2024

Interview

Advancing CAR-T therapies: navigating innovation, challenges, and the future of biopharma analytics

Adam Fung

09 September 2024

Interview

Exploring analytical assays and CMC challenges for viral vector-based therapies

Vladimir Slepushkin

19 June 2024

Interview

Advancing the analytical toolkit to drive viral gene delivery

Chelsea Amstuz, Itzcoatl Pla

18 June 2024

Interview

Navigating gene therapy QC: exploring the expanding AAV vector analytical toolkit

Van Hoang

12 June 2024

Interview

How will recent agency initiatives and likely future directions for regulatory CMC guidance impact the cellular immunotherapy space?

Adeyemi Afuwape

06 June 2024

Interview

Fit for function: developing potency assays reflective of the in vivo environment

Giorgio Zenere, Dirk Windgassen

10 May 2024

Interview

Challenges and benefits in harnessing platform processes for viral vector manufacture

Scott Cross, Christina Fuentes, Jacob Staudhammer

23 April 2024

Interview

Advancing AAV production scalability: enhancing purity, productivity, and yield

Ashish Saksule

19 March 2024

Interview

Quantitative viral vector characterization: prioritizing genome vector integrity

David Dobnik

21 February 2024

Interview

Current limitations & potential innovations in developing IND-enabling rAAV- & lentivirus-based gene therapy drug products

Rahul Kaushik

06 December 2023

Interview

Identifying and leveraging viral vector critical quality attributes & critical process parameters using process analytical technologies

Jonathan Appleby, John Churchwell

24 August 2023

Interview

Key considerations & development of regulatory guidance in CMC

David Ordóñez del Valle

11 April 2023

Interview

Exploring the evolution of upstream & downstream viral vector processing 

Francesca Vitelli

03 April 2023

Interview